🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Indiana › Indianapolis

Etid klinik pou Limfom Difize Gwo Selil B nan Indianapolis, IN

7 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Ap rekriteFaz 2
  • Saint Catherine Hospital, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Ap rekriteFaz 3
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06091865

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Ap rekriteFaz 2
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Indiana Blood and Marrow Transplantation, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Ap rekriteFaz 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Ap rekriteFaz 2
  • Saint Catherine Hospital, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Oct 20, 2025 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 2
  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2023 · NCT04920617

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.